226 related articles for article (PubMed ID: 27226556)
1. Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1).
Fang Z; Marshall CB; Yin JC; Mazhab-Jafari MT; Gasmi-Seabrook GM; Smith MJ; Nishikawa T; Xu Y; Neel BG; Ikura M
J Biol Chem; 2016 Jul; 291(30):15641-52. PubMed ID: 27226556
[TBL] [Abstract][Full Text] [Related]
2. New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis.
Takahara S; Inoue SI; Miyagawa-Tomita S; Matsuura K; Nakashima Y; Niihori T; Matsubara Y; Saiki Y; Aoki Y
EBioMedicine; 2019 Apr; 42():43-53. PubMed ID: 30898653
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.
Yaoita M; Niihori T; Mizuno S; Okamoto N; Hayashi S; Watanabe A; Yokozawa M; Suzumura H; Nakahara A; Nakano Y; Hokosaki T; Ohmori A; Sawada H; Migita O; Mima A; Lapunzina P; Santos-Simarro F; García-Miñaúr S; Ogata T; Kawame H; Kurosawa K; Ohashi H; Inoue S; Matsubara Y; Kure S; Aoki Y
Hum Genet; 2016 Feb; 135(2):209-22. PubMed ID: 26714497
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
[TBL] [Abstract][Full Text] [Related]
5. The molecular functions of RIT1 and its contribution to human disease.
Van R; Cuevas-Navarro A; Castel P; McCormick F
Biochem J; 2020 Aug; 477(15):2755-2770. PubMed ID: 32766847
[TBL] [Abstract][Full Text] [Related]
6. Mutations in RIT1 cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype.
Koenighofer M; Hung CY; McCauley JL; Dallman J; Back EJ; Mihalek I; Gripp KW; Sol-Church K; Rusconi P; Zhang Z; Shi GX; Andres DA; Bodamer OA
Clin Genet; 2016 Mar; 89(3):359-66. PubMed ID: 25959749
[TBL] [Abstract][Full Text] [Related]
7. RIT1 oncoproteins escape LZTR1-mediated proteolysis.
Castel P; Cheng A; Cuevas-Navarro A; Everman DB; Papageorge AG; Simanshu DK; Tankka A; Galeas J; Urisman A; McCormick F
Science; 2019 Mar; 363(6432):1226-1230. PubMed ID: 30872527
[TBL] [Abstract][Full Text] [Related]
8. RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy.
Cuevas-Navarro A; Wagner M; Van R; Swain M; Mo S; Columbus J; Allison MR; Cheng A; Messing S; Turbyville TJ; Simanshu DK; Sale MJ; McCormick F; Stephen AG; Castel P
Sci Adv; 2023 Jul; 9(28):eadf4766. PubMed ID: 37450595
[TBL] [Abstract][Full Text] [Related]
9. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.
Nemcikova M; Vejvalkova S; Fencl F; Sukova M; Krepelova A
Eur J Pediatr; 2016 Apr; 175(4):587-92. PubMed ID: 26518681
[TBL] [Abstract][Full Text] [Related]
10. Two cases of RIT1 associated Noonan syndrome: Further delineation of the clinical phenotype and review of the literature.
Milosavljević D; Overwater E; Tamminga S; de Boer K; Elting MW; van Hoorn ME; Rinne T; Houweling AC
Am J Med Genet A; 2016 Jul; 170(7):1874-80. PubMed ID: 27109146
[TBL] [Abstract][Full Text] [Related]
11. Guanosine triphosphatase stimulation of oncogenic Ras mutants.
Ahmadian MR; Zor T; Vogt D; Kabsch W; Selinger Z; Wittinghofer A; Scheffzek K
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7065-70. PubMed ID: 10359839
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic RIT1 mutations in lung adenocarcinoma.
Berger AH; Imielinski M; Duke F; Wala J; Kaplan N; Shi GX; Andres DA; Meyerson M
Oncogene; 2014 Aug; 33(35):4418-23. PubMed ID: 24469055
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and functional characterization of germ line KRAS mutations.
Schubbert S; Bollag G; Lyubynska N; Nguyen H; Kratz CP; Zenker M; Niemeyer CM; Molven A; Shannon K
Mol Cell Biol; 2007 Nov; 27(22):7765-70. PubMed ID: 17875937
[TBL] [Abstract][Full Text] [Related]
14. Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.
Cavé H; Caye A; Ghedira N; Capri Y; Pouvreau N; Fillot N; Trimouille A; Vignal C; Fenneteau O; Alembik Y; Alessandri JL; Blanchet P; Boute O; Bouvagnet P; David A; Dieux Coeslier A; Doray B; Dulac O; Drouin-Garraud V; Gérard M; Héron D; Isidor B; Lacombe D; Lyonnet S; Perrin L; Rio M; Roume J; Sauvion S; Toutain A; Vincent-Delorme C; Willems M; Baumann C; Verloes A
Eur J Hum Genet; 2016 Aug; 24(8):1124-31. PubMed ID: 26757980
[TBL] [Abstract][Full Text] [Related]
15. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation.
Kouz K; Lissewski C; Spranger S; Mitter D; Riess A; Lopez-Gonzalez V; Lüttgen S; Aydin H; von Deimling F; Evers C; Hahn A; Hempel M; Issa U; Kahlert AK; Lieb A; Villavicencio-Lorini P; Ballesta-Martinez MJ; Nampoothiri S; Ovens-Raeder A; Puchmajerová A; Satanovskij R; Seidel H; Unkelbach S; Zabel B; Kutsche K; Zenker M
Genet Med; 2016 Dec; 18(12):1226-1234. PubMed ID: 27101134
[TBL] [Abstract][Full Text] [Related]
16. Further evidence of the importance of RIT1 in Noonan syndrome.
Bertola DR; Yamamoto GL; Almeida TF; Buscarilli M; Jorge AA; Malaquias AC; Kim CA; Takahashi VN; Passos-Bueno MR; Pereira AC
Am J Med Genet A; 2014 Nov; 164A(11):2952-7. PubMed ID: 25124994
[TBL] [Abstract][Full Text] [Related]
17. An unexpected new role of mutant Ras: perturbation of human embryonic development.
Kratz CP; Niemeyer CM; Zenker M
J Mol Med (Berl); 2007 Mar; 85(3):227-35. PubMed ID: 17211612
[TBL] [Abstract][Full Text] [Related]
18. [RIT1: a novel gene associated with Noonan syndrome].
Arroyo-Carrera I; Solo de Zaldivar-Tristancho M; Martin-Fernandez R; Vera-Torres M; Gonzalez de Buitrago-Amigo JF; Botet-Rodriguez J
Rev Neurol; 2016 Oct; 63(8):358-362. PubMed ID: 27699752
[TBL] [Abstract][Full Text] [Related]
19. Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1.
Lo A; Holmes K; Kamlapurkar S; Mundt F; Moorthi S; Fung I; Fereshetian S; Watson J; Carr SA; Mertins P; Berger AH
Sci Signal; 2021 Nov; 14(711):eabc4520. PubMed ID: 34846918
[TBL] [Abstract][Full Text] [Related]
20. GTP hydrolysis mechanisms in ras p21 and in the ras-GAP complex studied by fluorescence measurements on tryptophan mutants.
Antonny B; Chardin P; Roux M; Chabre M
Biochemistry; 1991 Aug; 30(34):8287-95. PubMed ID: 1883817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
